Vaccines, Clinical Advancement, and Associated Immunology
A section of Vaccines (ISSN 2076-393X).
Section Information
Aims
The aim of the Section “Vaccines, Clinical Advancement, and Associated Immunology” is to highlight advances in vaccines and the associated immunology, vaccine clinical advancement, and vaccine-induced immunological changes, including immune-based adverse events induced by vaccines. This Section will provide a forum for novel insights into immunological mechanisms, translational applications, and the development of new vaccines.
Scope
We welcome articles focusing on the immunology of vaccines for infectious diseases, the design and development of new vaccines, and the clinical aspects of vaccinations, including adverse events and clinical entities that may occur following prophylactic and therapeutic vaccination. We also welcome submissions addressing preclinical and clinical studies related to vaccination in patients with immune-mediated disorders. The Section encourages translational research bridging experimental findings with human applications, and will consider original research articles, brief reports, reviews, and others relevant article types.
Keywords
- clinical immunology
- immune-mediated diseases
- vaccine adverse events
- vaccine immunopathology
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Immune Correlates of Protection in Vaccines, 2nd Edition (Deadline: 16 August 2025)
- Role of Gut Microbiota in Immune Tolerance and Vaccine Development (Deadline: 31 August 2025)
- Humoral and Cellular Response After Vaccination (Deadline: 31 October 2025)
- Novel Viral Vaccine and Molecular Immunology (Deadline: 31 October 2025)
- Advances in Allergy, Clinical Immunology, and Vaccines (Deadline: 31 October 2025)
- Immune-Mediated Diseases Following Vaccination (Deadline: 31 December 2025)
- Human Immune Responses to Infection and Vaccination (Deadline: 31 December 2025)
- Respiratory Viruses and Antiviral Immunity (Deadline: 31 January 2026)
- Analysis of Vaccine-Induced Adaptive Immune Responses (Deadline: 31 January 2026)
- Immune Responses in Patients with Inflammatory Bowel Disease After Vaccination (Deadline: 31 January 2026)
- Herpes Simplex Virus Infection, Immunity, and Vaccine Development (Deadline: 31 March 2026)
- Vaccines and Immunotherapy for Inflammatory Disease (Deadline: 31 March 2026)
- Immune Responses in Patients with Chronic Disease After Vaccination (Deadline: 30 April 2026)
- Research on Immune Response and Vaccines: 2nd Edition (Deadline: 30 April 2026)
- Mucosal Immunity and Vaccine (Deadline: 30 June 2026)
- Antibodies in Autoimmune, Chronic, and Infectious Diseases: Pathogenic Mechanisms, Biomarkers, and Vaccine Development (Deadline: 30 June 2026)
- Immunogenicity, Safety, and Coverage of Vaccines in Patients with Autoimmune Diseases (Deadline: 31 July 2026)